Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
मुख्य लेखकों: | Flossmann, O, Jones, R, Jayne, DR, Luqmani, R |
---|---|
स्वरूप: | Journal article |
भाषा: | English |
प्रकाशित: |
2006
|
समान संसाधन
-
Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
द्वारा: Mukhtyar, C, और अन्य
प्रकाशित: (2006) -
Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
द्वारा: Mukhtyar, C, और अन्य
प्रकाशित: (2008) -
Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
द्वारा: Saket Jha, और अन्य
प्रकाशित: (2019-01-01) -
Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
द्वारा: Zhi-Ying Li, और अन्य
प्रकाशित: (2020-08-01) -
Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives
द्वारा: Moog P, और अन्य
प्रकाशित: (2015-11-01)